Company: MVIS
Filing Date: 2025-02-03
Form Type: 424B5
Source: 0001493152-25-004622
Chunk: 0

Company: MICROVISION, INC.
Filing Date: 2025-02-03
Form: 424B5
Chunk 0
---
Filed Pursuant to Rule 424(b)(5)

Registration No. 333-272616

PROSPECTUS SUPPLEMENT

(To Prospectus dated March 1, 2024)

<div align='center'>MicroVision, Inc.

5,750,225 Shares of Common Stock

Warrants to Purchase up to 5,750,225 Shares of Common Stock</div>

We are offering directly to High Trail Special Situations LLC (the “investor”) up to 5,750,225 shares of our common stock, par value $0.001 per share, and warrants to purchase up to 5,750,225 shares of our common stock. This prospectus supplement also relates to the offering of the shares of common stock issuable upon exercise of the warrants. The warrants will have an exercise price of $1.57 per share of our common stock. The warrants will be exercisable at any time on or after the earlier of (i) the date that is six months after the date of issuance and (ii) the date that the Requisite Stockholder Approval (as defined in that certain Senior Secured Convertible Note due 2026, Certificate No. A-1, issued to the investor by the Company on October 23, 2024) is obtained and will terminate on the fifth anniversary of the initial exercise date. For a more detailed description of the warrants, see the section entitled “Description of Securities We Are Offering—Warrants” beginning on page S-7 of this prospectus supplement.

Our common stock is traded on The Nasdaq Global Market under the symbol “MVIS.” On January 31, 2025, the closing price of our common stock on The Nasdaq Global Market was $1.59 per share.

We have engaged WestPark Capital, Inc. and D. Boral Capital LLC as placement agents in connection with this offering. The placement agents are not purchasing or selling any shares of common stock or warrants in this offering.

The securities offered by this prospectus involve a high degree of risk. You should carefully consider the information under the heading “ Risk Factors” set forth on page S-4 of this prospectus supplement, on page 2 of the accompanying prospectus, as well as in our periodic reports filed with the Securities and Exchange Commission and incorporated by reference herein, in determining whether to purchase our securities.

Our executive offices are located at 18390 NE 68th Street, Redmond, Washington 98052, and our telephone number is (425